KARINE ZUMA: Open Payments
NPI 1467696583 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 18 payments from 12 companies in 2025. Trend: 2023 $1,408 · 2024 $2,533 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $101 |
| PFIZER INC. | 2 | $46 |
| Boston Scientific Corporation | 2 | $43 |
| Medtronic, Inc. | 1 | $36 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
Products named: CARDIOMEMS, ELIQUIS, WATCHMAN FLX, SELECTSECURE, VERQUVO, CAMZYOS, FARXIGA, REPATHA.
Industry payments across NY — which companies pay providers there.
